Evidence map›Paper›PMID 36353454›Full record

ArticleFrontiers in microbiology2022

The role of APTX4870 peptide in reducing cellular inflammatory responses by inhibiting

Xue Lin, Wei Jia, Gangning Feng, Yajing Su, Yuting Kang, Chen Zhang, Wenmiao Liu, Zhidong Lu, Di Xue

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Xue LinInstitute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, China.
Wei JiaNingxia Key Laboratory of Clinical and Pathogenic Microbiology, General Hospital of Ningxia Medical University, Yinchuan, China.
Gangning FengDepartment of Orthopaedics, General Hospital of Ningxia Medical University, Yinchuan, China.
Yajing SuNingxia Key Laboratory of Clinical and Pathogenic Microbiology, General Hospital of Ningxia Medical University, Yinchuan, China.
Yuting KangNingxia Key Laboratory of Clinical and Pathogenic Microbiology, General Hospital of Ningxia Medical University, Yinchuan, China.
Chen ZhangSchool of Education, Ningxia University, Yinchuan, China.
Wenmiao LiuNingxia Key Laboratory of Clinical and Pathogenic Microbiology, General Hospital of Ningxia Medical University, Yinchuan, China.
Zhidong LuDepartment of Orthopaedics, General Hospital of Ningxia Medical University, Yinchuan, China.
Di XueInstitute of Medical Sciences, General Hospital of Ningxia Medical University, Yinchuan, China.
Ningxia Medical University · CNNingxia Medical University General Hospital · CNNingxia University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis is a serious zoonotic disease caused by

Indexed as

cellular injurymultifunctional peptideMycobacteriummycolic acidNlrx1

Identifiers

PMID36353454
PMCPMC9638010
OpenAlexW4307190716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.